{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-026963","form_type":"8-K","ticker":"INFU","cik":"0001337013","company_name":"InfuSystem Holdings, Inc","filed_at":"2023-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.652212+00:00","generated_at":"2026-06-12T07:30:42.592659+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"InfuSystem reports record Q2 revenue of $31.7M (+17% YoY), net income $0.4M, raises FY guidance","bullets":["Net revenue record $31.7M (+17% YoY); Patient Services $19.3M (+12%), Device Solutions $12.4M (+27%).","Net income $0.4M ($0.02 diluted EPS) vs net loss -$0.2M (-$0.01) in Q2 2022.","Adjusted EBITDA $5.8M (18.2% margin), up 4% YoY and 36% sequentially.","FY 2023 guidance raised: revenue growth above prior 8-10% range; Adj EBITDA margin 17-18%."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-026963","json":"https://secwatch.observer/filing/0001628280-23-026963.json","markdown":"https://secwatch.observer/filing/0001628280-23-026963.md","text":"https://secwatch.observer/filing/0001628280-23-026963.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1337013/000162828023026963/0001628280-23-026963-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1337013/000162828023026963/infu-20230803.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T07:30:42.592659+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"17b4175d351b96fcdbb24ad32d8a7b60fe1aab5c","claim":"InfuSystem Holdings, Inc reported second quarter ended June 30, 2023 results: revenue $31.7 million, net income $0.4 million, or $0.02 per diluted share, EPS $0.02 per diluted share. Guidance raised.","evidence_excerpt":"InfuSystem Reports Second Quarter 2023 Financial Results Record Net Revenues of $31.7 million Representing 17% Growth From the Prior Year Rochester Hills, Michigan, August 3, 2023 – InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the second quarter ended June 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1337013/000162828023026963/0001628280-23-026963-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Revenue","value":"$31.7 million"},{"label":"Net income","value":"$0.4 million, or $0.02 per diluted share"},{"label":"EPS","value":"$0.02 per diluted share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}